
Public health officials in the UK are expressing concern about low uptake of a meningitis B vaccination campaign launched in response to disease outbreaks earlier in the year. Data from the UK Health Security Agency indicates that only 28.2% of 18- and 19-year-olds targeted by the programme have received an initial dose of the vaccine.
The vaccination initiative was announced in June following an outbreak in Kent and clusters of cases in Dorset and Berkshire that resulted in three deaths and ongoing health complications for some survivors. The government is offering two vaccine doses to eligible young adults, with the first dose deadline set for 31 December and second doses available until 31 March 2027. Individuals born between 1 September 2007 and 31 August 2008 are eligible, as are people under 25 who began university or residential further education this autumn. Among those who received a first dose, nearly 70% have already obtained their second dose.
Experts have highlighted the urgency of vaccination before the winter months, when meningitis B infections typically peak from December through March. University students face approximately seven times higher risk than non-students, with factors including shared housing, social gatherings, and large peer networks facilitating bacterial transmission. Dr Shamez Ladhani from the UKHSA urged eligible individuals to secure appointments promptly, while Prof Andrew Pollard stressed the vaccines’ effectiveness despite their inability to prevent all cases.
Several health professionals and organizations have questioned the current approach. Some have suggested reconsidering the December deadline and implementing broader promotional efforts through universities. The National Pharmacy Association, Meningitis Now charity, and the National Union of Students have called for routine meningitis B vaccination for adolescents rather than relying on time-limited campaigns. The Joint Committee on Vaccination and Immunisation previously recommended a routine meningitis B booster for 15-year-olds with prior infant vaccination and two doses for those who missed earlier immunization.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI